Down Syndrome in India-Diagnosis, Screening, and Prenatal Diagnosis

Clinics in Laboratory Medicine

Volumn 32, Issue 2, 2012, Pages 231-248

  Verma, Ishwar C ^a   Lall, Meena ^a   Dua Puri, Ratna ^a  

^a SIR GANGA RAM HOSPITAL   (India)

Author keywords

Cytogenetic studies; Down syndrome; Folate metabolism; Future therapies; Noninvasive prenatal diagnosis; Screening and prenatal diagnosis

Indexed keywords

ALPHA FETOPROTEIN; CHORIONIC GONADOTROPIN; FOLIC ACID; MEMANTINE; PENTETRAZOLE; PICROTOXIN; PREGNANCY ASSOCIATED PLASMA PROTEIN A;

ACUTE LEUKEMIA; AMNION FLUID ANALYSIS; ANEMIA; BACTERIAL ARTIFICIAL CHROMOSOME ON BEADS TECHNOLOGY; COGNITIVE DEFECT; CONGENITAL HEART DISEASE; CONGENITAL MALFORMATION; CYTOGENETICS; DISEASE ASSOCIATION; DOWN SYNDROME; ECHOGRAPHY; EPILEPSY; FIRST TRIMESTER PREGNANCY; FLUORESCENCE IN SITU HYBRIDIZATION; FOLATE METABOLISM; GENETIC COUNSELING; GENETIC ENGINEERING AND GENE TECHNOLOGY; GROWTH; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; INCIDENCE; INDIA; INFECTION; LIFESPAN; MATERNAL AGE; MATERNAL BLOOD; MENTAL DEFICIENCY; MULTIPLEX LIGATION DEPENDENT PROBE AMPLIFICATION; MYELOFIBROSIS; MYELOPROLIFERATIVE DISORDER; NON INVASIVE MEASUREMENT; NONHUMAN; POLYMERASE CHAIN REACTION; PRENATAL DIAGNOSIS; PREVALENCE; PRIORITY JOURNAL; PSYCHOMOTOR DISORDER; RECURRENT DISEASE; REVIEW; SCREENING; SECOND TRIMESTER PREGNANCY; THYROID DISEASE;

ANIMALS; CYTOGENETIC ANALYSIS; DOWN SYNDROME; FEMALE; HUMANS; MICE; PREGNANCY; PRENATAL DIAGNOSIS;

EID: 84862688523     PISSN: 02722712     EISSN: 15579832     Source Type: Journal    
DOI: 10.1016/j.cll.2012.04.010     Document Type: Review

References (80)

1. Megarbane A., Ravel A., Mircher C., et al. The 50th anniversary of the discovery of trisomy 21: The past, present, and future of research and treatment of Down syndrome. Genet Med 2009, 11(9):611-616.
2. Hattori M., Fujiyama A., Taylor T.D., et al. Chromosome 21 mapping and sequencing consortium. Nature 2000, 405:311-319.
3. Gardiner K., Herault Y., Lott I.T., et al. Down syndrome: from understanding the neurobiology to therapy. J Neuroscience 2010, 30(45):14943-14945.
4. Antonarakis S.E., Lyle R., Dermitzakis E.T., et al. Chromosome 21 and Down syndrome: from genomics to pathophysiology. Nat Rev Genet 2004, 5:725-738.
5. Wiseman F.K., Alford K.A., Tybulewicz V.L., et al. Down syndrome-recent progress and future prospects. Hum Mol Genet 2009, 18(R1):R75-R83.
6. Murthy S.K., Malhotra A.K., Mani S., et al. Incidence of Down Syndrome in Dubai, UAE. Med Princ Pract 2007, 16:25-28.
7. Canfield M.A., Honein M.A., Yuskiv N., et al. National estimates and race/ethnic-specific variation of selected birth defects in the United States, 1999-2001. Birth Defects Res A Clin Mol Teratol 2006, 76:747-756.
8. Roizen N.J., Patterson D. Down's syndrome. Lancet 2003, 361:1281-1289.
9. Verma I.C., Bijarnia S. The burden of genetic disorders in India and a framework for community control. Community Genetics 2002, 5(3):192-196.
10. Baird P.A., Sadovnick A.D. Maternal age-specific rates for Down syndrome: changes over time. Am J Med Genet 1988, 29:917-927.
11. Annual Report on Registration of Births & Deaths in Delhi 2010, Directorate of Economics and Statistics, & Office of the Chief Registrar (Births and Deaths), Civil Lines, Vikas Bhavan II, New Delhi.
12. Kava M.P., Tullu M.S., Muranjan M.N., et al. Down syndrome: clinical profile from India. Arch Med Res 2004, 35(1):31-35.
13. Menon P.S., Sachdev H.P., Verma I.C., et al. Developmental milestones of Down's syndrome patients in north India. Indian J Med Res 1981, 73:369-373.
14. Bhattacharyya R., Sanyal D., Roy K., et al. Correlation between physical anomaly and behavioral abnormalities in Down syndrome. J Pediatr Neurosci 2010, 5(2):105-110.
15. Bhatia S., Verma I.C., Shrivastava S. Congenital heart disease in Down syndrome: an echocardiographic study. Indian Pediatrics 1992, 29(9):1113-1116.
16. Nebesio T.D., Eugster E.A. Unusual thyroid constellation in Down syndrome: congenital hypothyroidism, Graves' disease, and hemiagenesis in the same child. J Pediatr Endocrinol Metab 2009, 22(3):263-268.
17. Bhat M.H., Saba S., Ahmed I., et al. Graves' disease in a Down's syndrome patient. J Pediatr Endocrinol Metab 2010, 23(11):1181-1183.
18. Awasthi A., Das R., Varma N., et al. Hematological disorders in Down syndrome: ten-year experience at a tertiary care centre in North India. Pediatr Hematol Oncol 2005, 22(6). 507-2.
19. Gathwala G., Dalal P., Dalal J.S., et al. Transient aplastic anemia in Down's syndrome-a rare association. Eur J Med Genet 2011, 54(3):341-342.
20. Sinha R., Thangaswamy C.R., Muthiah T., et al. Prolonged postoperative desaturation in a child with Down syndrome and atrial septal defect. Indian J Anaesth 2011, 55(6):608-610.
21. Arya R., Kabra M., Gulati S. Epilepsy in children with Down syndrome. Epileptic disorders: international epilepsy journal with videotape 2011, 13(1):1-7.
22. Joshi A.Y., Abraham R.S., Snyder M.R., et al. Immune evaluation and vaccine responses in Down syndrome: evidence of immunodeficiency?. Vaccine 2011, 29(31):5040-5046.
23. Sachdev H.S., Menon P.S., Verma I.C., et al. Physical growth of children with Down syndrome in India. Indian Journal Pediatr 1981, 48(390):85-89.
24. Glasson N., Sullivan E.J., Hussain S.G., et al. The changing survival profile of people with Down's syndrome: implications for genetic counselling. Clinical Genet 2002, 62(5):390-393.
25. Pradhan M., Dalal A., Khan F., et al. Fertility in men with Down syndrome: a case report. Fertil Steril 2006, 86(6). 1765,e1-3.
26. Verma I.C., Mathew S., Elango E., et al. Cytogenetic studies in Down syndrome. Indian Pediatrics 1991, 28:991-996.
27. Mutton D., Alberman E., Hook E.B. Cytogenetic and epidemiological findings in Down syndrome, England and Wales 1989 to 1993. National Down Syndrome Cytogenetic Register and the Association of Clinical Cytogeneticists. J Med Genet 1996, 33:387-394.
28. Jyothy A., Kumar K.S., Rao G.N., et al. Cytogenetic studies of 1001 Down syndrome cases from Andhra Pradesh, India. Indian J Med Res 2000, 111:133-137.
29. Mokhtar M.M., Abdel-Aziz A.M., Nazmy N.A., et al. Cytogenetic profile of Down syndrome in Alexandria, Egypt. Eastern Med Health J 2003, 9:37-44.
30. Devlin L., Morrison P.J. Mosaic Down's syndrome prevalence in a complete population study. Arch Dis Child 2004, 89:1177-1178.
31. Ahmed I., Ghafoor T., Samore N.A., et al. Down syndrome: clinical and cytogenetic analysis. J Coll Physicians Surg Pak 2005, 15(7):426-429.
32. Sheth F., Rao S., Desai M., et al. Cytogenetic analysis of Down syndrome in Gujarat. Indian Pediatr 2007, 44:774-777.
33. Acessed May 20, 2012. http://omim.org/entry/190685.
34. Mandava S., Koppaka N., Bhatia V., et al. Cytogenetic analysis of 1572 cases of Down syndrome: a report of double aneuploidy and novel findings 47,XY, t(14;21)(q13;q22.3)mat,+21 and 45,XX,t(14;21) in an Indian population. Genet Test Mol Biomarkers 2010, 14(4):499-504.
35. Kotwaliwale S.V., Dicholkar V.V., Motashaw N.D. Maternal transmission of translocation 2;21 associated with Down's syndrome. Journal Med Genet 1991, 28(6):415-416.
36. Balwan W.K., Kumar P., Raina T.R., et al. Double trisomy with 48, XXX+21 karyotype in a Down's syndrome child from Jammu and Kashmir, India. J Genet 2008, 87(3):257-259.
37. Verma I.C., Gupta A.K., Devanagondi B.S. Down syndrome: maternal age in 615 cases in india and its implications in genetic counseling. Indian pediatrics 1975, 12(12):1239-1245.
38. Dagna-Bricarelli F., Pierluigi M., Perroni L., et al. High efficiency in the attribution of parental origin of nondisjunction in trisomy 21 by both cytogenetic and molecular polymorphisms. Hum Genet 1988, 79:124-127.
39. Jacobs P.A., Hassold T.J. The origin of numerical chromosomal abnormalities. In Adv Hum Genet 1995, 33:101-133.
40. Raman R. Down syndrome in India. Genetic disorders of the Indian subcontinent 2004, 171-184. Kluwer Academic Publishers, Dordrecht. D. Kumar (Ed.).
41. Ghosh S., Bhaumik P., Ghosh P., et al. Chromosome 21 non-disjunction and Down syndrome birth in an Indian cohort: analysis of incidence and aetiology from family linkage data. Genet Res 2010, 92(3):189-197.
42. Malini S.S., Ramachandra N.B. Influence of advanced age of maternal grandmothers on Down syndrome. BMC Med Genet 2006, 7:4.
43. Leyton C., Mergudich D., de la Torre D., et al. Impaired chromosome segregation in plant anaphase after moderate hypomethylation of DNA. Cell Prolif 1995, 28:481-496.
44. James S.J., Pogribna M., Pogribny I.P., et al. Abnormal folate metabolism and mutation in the methylenetetrahydrofolate reductase (MTHFR) gene may be maternal risk factors for Down syndrome. Am J Clin Nutr 1999, 70:495-501.
45. Hobbs C.A., Sherman S.L., Yi P., et al. Polymorphisms in genes involved in folate metabolism as maternal risk factors for Down syndrome. Am J Hum Genet 2000, 67:623-630.
46. Petersen M., Grigoriadou M., Mikkelsen M. A common mutation in the methylenetetrahydrofolate reductase gene is not a risk factor for Down syndrome. Am J Hum Genet 2000, 67(Suppl 2):141.
47. Cyril C., Rai P., Chandra N., et al. MTHFR Gene variants C677T, A1298C and association with Down syndrome: a Case-control study from South India. Indian J Hum Genet 2009, 15(2):60-64.
48. Kohli U., Arora S., Kabra M., et al. Prevalence of MTHFR C677T polymorphism in north Indian mothers having babies with Trisomy 21 Down syndrome. Down's syndrome, research and practice. Journal of the Sarah Duffen Centre/University of Portsmouth 2008, 12(2):133-137.
49. Bean L.J., Allen E.G., Tinker S.W., et al. Lack of maternal folic acid supplementation is associated with heart defects in Down syndrome: a report from the National Down Syndrome Project. Birth defects research Part A, Clinical and Molecular Teratology 2011, 91(10):885-893.
50. Girisha K.M., Sharda S.V., Phadke S.R. Issues in counseling for Down syndrome. Indian Pediatr 2007, 44(2):131-133.
51. Bull M.J. Committee on Genetics. Health supervision for children with Down syndrome. Pediatrics 2011, 128(2):393-406.
52. Weijerman M.E., de Winter J.P. Clinical practice. The care of children with Down syndrome. Eur J Pediatr 2010, 169(12):1445-1452.
53. Gardner R.J.M., Sutherland G.R. Down syndrome. Other Full aneuploides, and Polyploidy. Chromosome abnormalities and genetic counseling. Oxford Monographs on Medical Genetics. No 46 2004, 249-263. Oxford University Press, New York. 3rd edition.
54. Driscoll D.A., Gross S.J. Professional Practice Guidelines Committee. Screening for fetal aneuploidy and neural tube defects. Genet Med 2009, 11(11):818-821.
55. Malone F.D., Canick J.A., Ball R.H., et al. First-trimester or second-trimester screening, or both, for Down's syndrome for the first trimester and second trimester evaluation of risk (FASTER) research consortium. N Engl J Med 2005, 353:2001-2011.
56. Pandya P.P., Goldberg H., Walton B., et al. The implementation of first-trimester scanning at 10-13 weeks' gestation and the measurement of fetal nuchal translucency thickness in two maternity units. Ultrasound Obstet Gynecol 1995, 5(1):20-25.
57. Bredaki F.E., Wright D., Matos P., et al. First-trimester screening for trisomy 21 using alpha-fetoprotein. Fetal Diagn Ther 2011, 30:215-218.
58. Nicolaides K.H. Screening for fetal aneuploides at 11-13 weeks. Prenat Diag 2011, 31:7-15.
59. Cicero S., Curcio P., Papageorghiou A., et al. Absence of nasal bone infetuses with trisomy 21 at 11-14 weeks of gestation: an observational study. Lancet 2001, 358:1665-1667.
60. Nicolaides K.H. Turning the pyramis of prenatal care. Fetal Diagn Ther 2011, 29:183-196.
61. Kagan K.O., Cicero S., Staboulidou I., et al. Fetal nasal bone in screening for trisomies 21, 18 and 13 and Turner syndrome at 11-13 weeks of gestation. Ultrasound Obstet Gynecol 2009, 33:259-264.
62. Maiz N., Valencia C., Kagan K.O., et al. Ductus venosus Doppler in screening for trisomies 21, 18 and 13 and Turner syndrome at 11-13 weeks of gestation. Ultrasound Obstet Gynecol 2009, 33:512-517.
63. Kagan K.O., Valencia C., Livanos P., et al. Tricuspid regurgitation in screening for trisomies 21, 18 and 13 and Turner syndrome at 11 + 0-13 + 6 weeks of gestation. Ultrasound Obstet Gynecol 2009, 33:18-22.
64. Guanciali-Franchi P., Iezzi I., Palka C., et al. Comparison of combined, stepwise sequential, contingent, and integrated screening in 7292 high-risk pregnant women. Prenat Diagn 2011, 31(11):1077-1081.
65. Benacerraf B.R., Neuberg D., Bromley B., et al. Sonographic scoring index for prenatal detection of chromosomal abnormalities. J Ultrasound Med 1992, 11:449-458.
66. Nyberg D.A., Luthy D.A., Williams M.A., et al. Genetic sonogram: computerized assessment of risk for Down syndrome based on obstetric US findings during the second trimester (abstr). Radiology 1996, 201(P):160.
67. Gupta R., Thomas R.D., Sreenivas V., et al. Ultrasonographic femur-tibial length ratio: a marker of Down syndrome from the late second trimester. Am J Perinatol 2001, 18(4):217-224.
68. Kabra M., Saxena R., Chinnappan D., et al. Karyotyping of at risk fetuses by cordocentesis in advanced gestation. Indian J Med Res 1996, 104:288-291.
69. Mathur R., Dubey S., Hamilton S., et al. Rapid prenatal karyotyping using foetal blood obtained by cordocentesis. Nat Med J India 2002, 15(2):75-77.
70. Hahn S., Jackson L.G., Zimmermann B.G. Prenatal diagnosis of fetal aneuploidies: post-genomic developments. Genome Med 2010, 2(8):50.
71. Shaffer L.G., Coppinger J., Morton S.A., et al. The development of a rapid assay for prenatal testing of common aneuploidies and microdeletion syndromes. Prenat Diagn 2011, 31(8):778-787.
72. Chiu R.W., Akolekar R., Zheng Y.W., et al. Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validation study. BMJ 2011, 342:c7401.
73. Palomaki G.E., Kloza E.M., Lambert-Messerlian G.M., et al. DNA sequencing of maternal plasma to detect Down syndrome: an international clinical validation study. Genet Med 2011, 13:913-920.
74. Papageorgiou E.A., Karagrigoriou A., Tsaliki E., et al. Fetal-specific DNA methylation ratio permits noninvasive prenatal diagnosis of trisomy 21. Nat Med 2011, 17:510-513.
75. ISPD Rapid Response Statement. Prenatal detection of Down syndrome using massively parallel sequencing (MPS): a rapid response statement from a committee on behalf of the Board of the International Society for Prenatal Diagnosis, 24 October 2011 Accessed April 1, 2012. http://www.ispdhome.org.
76. Benn P., Cuckle H., Pergament E. Non-invasive prenatal diagnosis for Down syndrome: the paradigm will shift, but slowly. Ultrasound Obstet Gynecol 2012, 39:127-130.
77. Fernandez F., Morishita W., Zuniga E., et al. Pharmacotherapy for cognitive impairment in a mouse model of Down syndrome. Nat Neurosci 2007, 10:411-413.
78. Costa C., Scott-McKean J.J., Stasko M.R. Acute injections of the NMDA receptor antagonist memantine rescue performance deficits of the Ts65Dn mouse model of Down syndrome on a fear conditioning test. Neuropsychopharmacology 2007, 33:1624-1632.
79. Salehi M., Faizi D., Colas J., et al. Restoration of norepinephrine-modulated contextual memory in a mouse model of Down syndrome. Sci Transl Med 2009, 1. 7ra17.
80. Wiseman F.K. Cognitive enhancement therapy for a model of Downs syndrome. Sci Transl Med 2009, 1:1.